Product Overview
Drug Ingredients:
Aniracetam
Chemical Components:
The main ingredient of this product is aniracetam, whose chemical name is 1-(4-methoxybenzoyl)-2-pyrrolidone. Molecular Formula: C₁₂H₁₃NO₃ Molecular Weight: 219.24
Appearance:
This product is a capsule containing a white to off-white powder.
Indications:
It is suitable for memory loss in middle-aged and elderly people and memory loss following cerebrovascular disease.
Dosage and Administration:
Oral administration: 2 capsules 3 times a day for 1-2 months or as directed by a physician. The dosage and duration of treatment may be increased or decreased depending on the patient's condition and medication reactions.
Adverse Reactions:
Adverse reactions to this product include dry mouth, loss of appetite, constipation, dizziness, and drowsiness, which disappear upon discontinuation of the drug. Excitement, restlessness, and generalized eczema have occasionally been reported.
Contraindications:
This product is contraindicated in patients with allergies to this product or intolerance to other pyrrolidone-type medications.
Precautions:
1. Dosage should be adjusted appropriately for patients with significant liver dysfunction. 2. This product may aggravate symptoms in patients with Huntington's chorea. 3. The recommended safe dosage range is 300-1800 mg/day.
Overdose:
This study has not been conducted and no reliable references are available.
Targeted Population:
This study has not been conducted and no reliable references are available. This study has not been conducted and no reliable references are available. This study has not been conducted and no reliable references are available. Usual Dose: For patients aged 70 years and above, 0.1 g three times a day. For patients under 70 years old, 0.2 g three times a day.
Drug Interactions:
This study has not been conducted and no reliable references are available.
Manufacturer:
Wuxi Kaifu Pharmaceutical Co., Ltd.
Pharmacological Action:
This product is a cyclized derivative of γ-aminobutyric acid (GABA) that improves brain function. It can cross the blood-brain barrier and selectively act on the central nervous system. Animal studies have shown that this product significantly enhances the memory retrieval process of discrimination learning in normal rats, counteracts hypoxia-induced memory impairment, and effectively improves memory impairment caused by certain causes.
Pharmacokinetics:
After oral administration in humans, the average elimination half-life of the parent drug from the blood is 22 minutes, and blood concentrations are undetectable after 4 hours. Animal studies have shown that this product is primarily distributed in the gastrointestinal tract, kidneys, liver, brain, and blood. After 24 hours, 77-85% is excreted in the urine and 4% in the feces. The main metabolites in urine are N-(4-amino)-benzamidobutyric acid and 5-hydroxy-2-pyrrolidone.
Dosage Form:
Capsules
Specifications:
0.1g
Packaging:
Solid pharmaceutical plastic bottle. 36 capsules/bottle
Storage:
Protected from light and stored in a sealed container.
Expiry Period:
36 months
Approval Number:
National Medicine Standard No. H20056350
